SAGENT

Live / Registered — Registered (as of 28 Apr 2026)

What this means for you

Registered since 28 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Apr 2032: the §8 declaration of use).

Record

Serial number
98977958
Registration number
8235796
Mark type
Design + words
Filed
08 Jul 2024
Published for opposition
04 Mar 2025
Registered
28 Apr 2026
Next maintenance filing
§8 declaration of use, due by 28 Apr 2032 (grace period to 28 Oct 2032)
Attorney of record
Tamara A. Miller

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceuticals, namely, anesthetics, anti-infectives, antiemetics, blood modifiers, and oncolytics; pharmaceuticals for treatment of cancer; injectable drugs and therapeutic solutions for the treatment of cancer, infections, and pain; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors

Owner

Prior registrations

Prosecution history

  • 28 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 28 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
  • 03 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 03 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 03 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 23 Oct 2025 — USE AMENDMENT FILED
  • 01 Apr 2026 — RESPONSE TO ITU OFFICE ACTION ENTERED
  • 03 Apr 2026 — DIVISIONAL PROCESSING COMPLETE
  • 23 Oct 2025 — DIVISIONAL REQUEST RECEIVED
  • 01 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 10 Mar 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
  • 10 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 23 Oct 2025 — TEAS REQUEST TO DIVIDE RECEIVED
  • 23 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
  • 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Rightsy